retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Agonism Based Therapies for | Current Cardiovascular Risk Reports Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces

Description

The findings imply that GLP-1 may have an impact on reproductive hormones, pointing to possible treatment approaches for type 2 diabetes and obesity-related hypogonadism in males (105)

Approach: His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health

GLP-1 works beautifullystimulating insulin, suppressing glucagon, and slowing gastric emptyingbut it has a fatal flaw: It is destroyed by the enzyme DPP-4 within minutes of entering the bloodstream

The primary outcome was the mean HbA1c change from baseline to 56 weeks, which was significantly reduced in both semaglutide groups against sitagliptin